Methyl (S)-2-methoxy-5-(((1-(5-phenyl-1H-imidazol-2-yl)ethyl)amino)methyl)benzoate oxalate, 98%, 5g

1-Bromomethyl-7,7-dimethyl-bicyclo[2.2.1]heptan-2-one, 95.0%, 250mg

(butan-2-yl)[(4-tert-butylphenyl)methyl]amine, 95.0%, 2g

(5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)methanol (Etoricoxib Impurity), 97%, 50mg

3-Bromo-5-fluoroisonicotinonitrile, 95.0%, 5g

tert-Butyl 2-Oxoazetidine-1-carboxylate, 97.0%, 100mg

Decahydroisoquinoline (cis- and trans- mixture, predominantly cis-isomer)>98.0%(GC)5mL

2-Bromo-5-methoxypyridin-4-amine, 97%, 25g

9-Oxo-9H-fluorene-4-carboxylic acid, 95.0%, 10g

3-Amino-4-fluorobenzenesulfonamide, 95+%, 1g

N-(4-(N-(pyridin-4-yl)sulfamoyl)phenyl)acetamide, 97%, 1g

(S)-2-(3,4-difluorophenyl)oxirane, 95%, 250mg

3-Indolepropionic Acid>98.0%(T)25g